Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Public ClinicalTrials.gov record NCT01732627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary objectives: * To describe the antibody responses to meningococcal serogroups A, C, Y, and W 135, measured by serum bactericidal assay using human complement (hSBA) and baby rabbit complement (rSBA), induced by a single dose of Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein (MenACYW) Conjugate vaccine or Menomune® - A/C/Y/W 135. * To describe the safety profile of a single dose of MenACYW Conjugate vaccine or Menomune® - A/C/Y/W 135.
Study identification
- NCT ID
- NCT01732627
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 301 participants
Conditions and interventions
Conditions
Interventions
- Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine Biological
- Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W 135 Combined Biological
Biological
Eligibility (public fields only)
- Age range
- 56 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2012 (Actual)
- Primary completion
- Jan 17, 2013 (Actual)
- Completion
- Jan 17, 2013 (Actual)
- Last update posted
- Apr 4, 2022
2012 – 2013
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Denver | Colorado | 80239 | — |
| Not listed | Milford | Connecticut | 06460 | — |
| Not listed | Edina | Minnesota | 55435 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Columbus | Ohio | 43212 | — |
| Not listed | Anderson | South Carolina | 29621 | — |
| Not listed | Murray | Utah | 84123 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01732627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01732627 live on ClinicalTrials.gov.